In a recent study, researchers at Tel Aviv University (TAU) have demonstrated that the CRISPR/Cas9 system is very effective in treating metastatic cancers- a significant step on the way to finding a cure for cancer. Funded by ICRF (Israel Cancer Research Fund), the results of the groundbreaking study, were published in November 2020 in Science Advances.
Company :-Good Relations India
User :- Uday Singh
Email :-uday.singh@gri.co.in
Mobile:- 9582180149